The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Melbourne, Australia
11-50 Employees
2010
In addition, we provide access to training courses for all different levels of expertise. Euro-BioImaging’s mission is to provide you with imaging services that bridge biological and biomedical imaging and facilitate innovative and world-class research. Access to imaging technologies: We offer access to a range of imaging technologies to allow you image across the scales at one of our 35 Nodes, located in 18 countries and the European Molecular Biology Laboratory, EMBL. Expert training and support: Each Node is staffed with personnel who can provide the support required to maximise the output of your research project. Galaxy is a free, open-source cloud-based system for analyzing data, authoring workflows and much more. Many Euro-BioImaging Nodes are working on innovative image analysis and image data management solutions and the next Euro-BioImaging User Forum is designed to highlight these. The annual meeting of the European Light Microscopy Initiative (ELMI), is a key event in the calendar of hundreds of scientists and developers.
+
Featured
Euro-Bioimaging
... Funding instruments available at specific Euro-BioImaging ...
+
Featured
PPBI Euro-BioImaging Node
... PPBI Euro-BioImaging ...
Figino Serenza, Italy
11-50 Employees
2005
The updated products and services line dedicated to Doctors, Radiologists and Dental Technicians, for the complete management of the digital dentistry workflow. Our Team of highly qualified experts, Biomedical Engineers and Dental Technicians at your complete disposal to always guarantee support and assistance for all your needs. Our history3DIEMME is a services Company aimed at Professionals and Companies to provide advice and design in the technical and biomedical field. Since 2006 the company has worked in the dental and maxillofacial sector supporting Doctors and Dental technicians worldwide in managing clinical cases with minimally invasive and digital technologies. Our missionTo be the reference company for the digital management of minimally invasive surgery via the implementation of software that integrates all the information required for the Patient's customised rehabilitation in one open system.
+
Featured
Materials - 3DIEMME - Bioimaging Tecnologies
... Materials - 3DIEMME - Bioimaging ...
Paterna, Spain
2018
Dawako Medtech is a medical device company with a vision to revolutionize healthcare by advancing the field of Wearable. Dawako’s mission is to provide healthcare professionals with accessible tools for faster and more precise insights into patient health. Dawako Medtech’s Wearable Bioimaging Technology integrates two components:. Dawako’s highly cost-effective, Wearable AI Ultrasound and Biosignals technology is creating a new paradigm in the field of traditional medical imaging.
+
Featured
Wearable Bioimaging in Motion
... BioSensonics, bioimaging, ultrasound, wearable, wearable bioimaging, medical device, imaging biomarker, medical imaging, sports science, artificial intelligence, musculoskeletal, MSK, ...
Turku, Finland
1-10 Employees
2016
Euro-BioImaging Finland is the Finnish service organization for Euro-BioImaging. We offer academic and industrial researchers open access to biological and biomedical imaging technologies, services and training, through two multisited Nodes: Finnish Advanced Microscopy Node (FiAM) and Finnish Biomedical Imaging Node (FiBI).
+
Featured
Welcome to Euro-BioImaging Finland
... Welcome to Euro-BioImaging ...
Christchurch, New Zealand
11-50 Employees
2007
We are able to transition seamlessly between translation studies spanning from imaging phantoms to in vivo murine models. We are glad to have the latest spectral (multi-energy) CT system which enables non-invasive imaging and quantification of various components simultaneously in small animals. We are fortunate to have the MARS scanner at HKU Department of Diagnostic Radiology with it state-of-the-art photon-counting detectors and multi-spectral energy capability. MARS Bioimaging Ltd (MBI) was founded in 2007 to commercialize the cutting-edge Medipix technology and bring photon-counting CT to the clinic. MBI has established itself as the world’s leading research and development group in spectral molecular imaging, and to-date has delivered the world’s first commercial pre-clinical spectral CT scanner. MBI works closely with customers to provide a wide range of spectral imaging solutions for applications ranging from cancer detection to development of novel contrast agents. Mark Figgitt is a highly respected executive and director with four decades of technology and leadership experience, including leading growth for health software, cardiology and radiology providers, Change Healthcare ANZ and HSTM Group NZ for the past six years. Professor Anthony Butler is a clinical radiologist with an interest in developing new imaging technologies.
+
Featured
MARS Bioimaging
... MARS Bioimaging ...
Hod HaSharon, Israel
11-50 Employees
2015
HT BioImaging mission is to detect and classify cancer early on the spot. Shani has over 11 years of experience in the tech, defense & aviation industry as a developer, system engineer, and R&D team leader.
+
Featured
About us | HT BioImaging
... About us | HT BioImaging ...
Upland, United States
101-250 Employees
1932
Analytik Jena US, formerly UVP, designs and manufactures ultraviolet product solutions for multiple applications. In 2013, UVP was acquired by Analytik Jena AG (now Analytik Jena GmbH) which is based in Jena, Germany. The UVP Company name was changed to Analytik Jena US LLC, and operates as part of Analytik Jena's Life Science Business Unit. Analytik Jena US, formerly UVP, designs and manufactures ultraviolet product solutions for applications including criminology, electrophoresis, thin-layer chromatography, sterilization, sanitation, toxicology, inspection, non-destructive testing and UV curing. We are part of a successful family company. Analytik Jena is a global leader in life science products, supplying BioImaging Systems for academic, pharmaceutical and biotechnology applications. Analytik Jena continues to create innovative products and specialize in fluorescence and luminescence-based imaging applications for proteomics, genomics and plant imaging. Analytik Jena US's team provides extensive technical and scientific support for our customer's research applications.
+
Featured
BioImaging
... BioImaging Systems - uvp. ...
+
Featured
water suspendable silicon quantum dot for bioimaging applications
... suspendable silicon quantum dot for bioimaging applications can be purchased with world wide ...
Montpellier, France
251-500 Employees
2012
France-BioImaging is a National Infrastructure in Biology and Health (INBS) laureate in 2011 of the national Program “Investissements d’Avenir” (PIA-ANR) in the field of biological imaging. France-BioImaging aims at creating the most efficient adoption of the latest advances in all technologies and methods related to microscopy, by the users of the imaging facilities. These technologies and methods, reinforced by a strong support in computational analysis, provide quantitative measures and integrative understanding of a wide range of cell and tissue activities in biological models, from the simplest, to small animals in normal and pathological situations.
+
Featured
About - France-BioImaging
... France BioImaging in ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Bioimaging
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 38 |
| Amount of suitable service providers | 29 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1932 |
| Youngest suiting company | 2020 |
Bioimaging refers to a collective set of techniques and processes utilized to visualize biological materials, including cells, tissues, and entire organisms, in both their normal and diseased states. This technology encompasses various methods such as microscopy, fluorescence imaging, magnetic resonance imaging (MRI), and computed tomography (CT), each offering unique insights into the structural and functional properties of biological specimens. The primary objective of bioimaging is to gain a deeper understanding of biological processes at the molecular, cellular, and systemic levels, thereby facilitating advancements in the diagnosis, treatment, and monitoring of diseases. Its role within biomedical research and clinical practice is pivotal, as it enables scientists and healthcare professionals to observe biological phenomena in real-time and in vivo, leading to more accurate assessments of physiological conditions and the effects of therapeutic interventions. The impact of bioimaging is profound, significantly contributing to the accelerated pace of discovery in fields such as oncology, neurology, and developmental biology. Through the detailed visualization it provides, bioimaging has become an indispensable tool in the quest for understanding the complexities of life, revolutionizing both research methodologies and medical diagnostics, thereby enhancing patient care and outcomes.
1. Enhanced Resolution and Detail
Bioimaging techniques, such as fluorescence microscopy and MRI, offer superior resolution compared to traditional imaging methods. This allows for the visualization of cellular and molecular processes in unprecedented detail, facilitating a deeper understanding of biological functions and disease mechanisms.
2. Non-Invasive Observation
One of the significant advantages of bioimaging is its non-invasive nature, particularly in clinical settings. Techniques like ultrasound and MRI provide detailed images of the internal structures of the body without requiring surgical intervention, minimizing the risk to patients and improving recovery times.
3. Real-Time Monitoring
Bioimaging enables the real-time monitoring of biological processes, which is critical for dynamic studies and medical diagnostics. This capability allows researchers and clinicians to observe the immediate effects of treatments or changes in physiological states, offering insights that can lead to more effective therapeutic strategies.
4. Quantitative Analysis
Modern bioimaging techniques incorporate quantitative analysis tools, allowing for the precise measurement of biological parameters. This quantification is essential for the accurate assessment of disease progression, treatment efficacy, and for conducting reproducible research.
While evaluating the different suppliers make sure to check the following criteria:
1. Technology Compatibility
Ensure the supplier's bioimaging technology is compatible with your current systems and workflows. This includes software integration and hardware compatibility.
2. Image Quality and Resolution
High image quality and resolution are crucial for detailed analysis. Verify the supplier offers superior imaging capabilities that meet your research needs.
3. Advanced Features and Capabilities
Look for advanced features like 3D imaging, live-cell imaging, and high-throughput capabilities that can enhance your research outcomes.
4. Support and Maintenance Services
Consider the level of support and maintenance services offered. Reliable technical support and easy access to maintenance can significantly reduce downtime.
5. Cost-Effectiveness
Evaluate the cost in relation to the technology and services provided. Ensure the pricing aligns with your budget and the value it brings to your projects.
6. Reputation and Reviews
Research the supplier’s reputation within the scientific community. Positive reviews and testimonials can indicate reliability and quality.
Bioimaging technology plays a crucial role in the pharmaceutical industry by enabling detailed visualization of drugs' effects on cellular processes. This visualization aids in drug development by providing insights into drug efficacy and mechanisms of action, significantly reducing the time and cost associated with bringing new medications to market. In the agriculture sector, bioimaging is instrumental in genetic modification and plant breeding. Through high-resolution imagery, scientists can observe and analyze the physiological changes in crops under various conditions, leading to the development of more resilient and high-yielding plant varieties. This application of bioimaging ensures food security and sustainability in agriculture. The field of environmental monitoring also benefits from bioimaging techniques. Researchers use these technologies to assess the health of ecosystems and the impact of pollutants on wildlife. By examining the bioaccumulation of hazardous substances in organisms, scientists can gauge environmental degradation and inform conservation strategies. In medical diagnostics, bioimaging is indispensable for early detection and treatment of diseases. Technologies such as MRI and CT scans provide clinicians with detailed internal images, allowing for accurate diagnoses and tailored treatment plans. This application not only improves patient outcomes but also reduces healthcare costs by minimizing the need for invasive procedures.
Bioimaging technology, encompassing a wide array of techniques for visualizing biological processes and structures at various scales, currently spans across multiple Technology Readiness Levels (TRLs) due to its diverse applications and the varying maturity of its methods. Techniques such as magnetic resonance imaging (MRI) and X-ray computed tomography (CT) are at TRL 9, indicating they are fully mature, widely deployed in clinical settings, and have a substantial body of research supporting their efficacy and safety. Conversely, cutting-edge methods like super-resolution microscopy and optogenetics are at lower TRLs, around 4-6, reflecting their ongoing development, validation in controlled environments, and the initial stages of real-world application. This disparity arises primarily due to technical challenges, including the need for more sophisticated computational algorithms to process and analyze high-resolution data, the development of more sensitive and specific bioimaging agents, and the integration of emerging technologies with existing medical imaging infrastructures. Furthermore, regulatory approval processes also play a significant role in the progression of TRLs, particularly for techniques that involve novel biomarkers or genetic modifications, requiring extensive validation to ensure safety and efficacy. Thus, the current TRL of bioimaging is a spectrum, influenced by both the inherent technical complexities of advancing imaging capabilities and the regulatory landscape governing their clinical adoption.
In the Short-Term, advancements in bioimaging are set to focus on enhancing resolution and reducing the time required for imaging processes. Innovations such as high-throughput screening and real-time imaging techniques are expected to become more mainstream. These developments will allow researchers and medical professionals to observe cellular processes with unprecedented clarity and speed, enabling quicker diagnoses and more detailed cellular research. The Mid-Term phase is likely to witness the integration of artificial intelligence and machine learning with bioimaging technologies. This combination will not only improve image analysis accuracy but also predict outcomes by recognizing patterns undetectable to the human eye. Furthermore, the development of portable bioimaging devices is anticipated, making sophisticated imaging technologies more accessible and facilitating point-of-care diagnostics in remote areas. Looking into the Long-Term, the focus will shift towards the development of non-invasive and minimally invasive bioimaging techniques, which will significantly reduce patient discomfort and risk. Innovations in molecular imaging are expected to enable the visualization of cellular and molecular processes in real-time, opening new avenues for personalized medicine and targeted therapies. The evolution of bioimaging into a more patient-friendly tool will revolutionize diagnostics, treatment planning, and disease monitoring.
